Other News

Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension

MLS-101 is a Highly Selective Aldosterone Synthase Inhibitor Designed to Address Abnormally Elevated Aldosterone, an Underlying Cause of Hypertension Prevalent in a Significant Portion of Patients Derek DiRocco of RA Capital Management and Olivier Litzka, PhD of Andera Partners Join Mineralys Board of Directors PHILADELPHIA, June 8, 2022 /PRNewswire/ — Mineralys Therapeutics, Inc., a private, […]

PZU Zdrowie (Eng. PZU Health) rolls out Cardiomatics solution for precise diagnostics in cardiology across their clinics.

CRACOW, Poland, June 8, 2022 /PRNewswire/ — The AI-based system developed by Cardiomatics streamlines the work of cardiologists by supporting ECG interpretation. Now, the doctors at PZU Zdrowie (a Polish healthcare provider associated with PZU Group – one of the top insurance companies in East-Central Europe) will be able to take advantage of its […]

CorVista Health Announces Drs. Vallerie V. McLaughlin and Mark G. Rabbat Join Medical Advisory Board

WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the expansion of their Medical Advisory Board with the appointment of Drs. Vallerie V. McLaughlin and Mark G. Rabbat. The expansion of the Medical Advisory Board reflects the company’s focus on pulmonary hypertension, coronary artery disease […]

OKAMI MEDICAL ANNOUNCES FDA 510(k) CLEARANCE OF THE LOBO-7 and LOBO-9 VASCULAR OCCLUDERS TO ADDRESS A WIDE RANGE OF PERIPHERAL EMBOLIZATION CASES

ALISO VIEJO, Calif., June 7, 2022 /PRNewswire/ — Okami Medical Inc., a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LOBO-7 and LOBO-9 Vascular Occluders, the latest addition to the […]

First Patient Enrolled in SELUTION SLR IDE BTK Study

GENEVA, June 7, 2022 /PRNewswire/ — The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon, just one week after receiving IDE approval. “I am excited to begin an important trial which will establish the evidence that this novel technology […]

Manny Villafaña’s Medical 21 Unveils Groundbreaking MAVERICS Graft System

The MAVERICS graft system is a revolutionary functional artificial artery that is designed to eliminate the need for vessel harvesting in cardiac bypass surgery patients — creating a more efficient, cost-effective, and less invasive procedure. MINNEAPOLIS, June 7, 2022 /PRNewswire/ — Led by founder and CEO Manny Villafaña, Ph.D. Sc., Medical 21 is a […]

Texas Health Earns National Cardiac Care Awards

ARLINGTON, Texas, June 7, 2022 /PRNewswire/ — With heart disease being the leading cause of death in the United States, Texas Health Resources is addressing the problem with quality, science-based guidelines for treating heart attack patients. This focus on quality care helped eight Texas Health facilities earn this year’s American College of Cardiology’s […]

ScImage and DiA Imaging Analysis Team Up to Infuse AI into Echocardiography Labs

The combination of ScImage’s Cloud-centric and DiA’s AI-based cardiac ultrasound software will offer echo labs of any size a unique workflow solution  LOS ALTOS, Calif., and BEER SHEVA, Israel, June 7, 2022 /PRNewswire/ — ScImage Inc., a leading provider of Enterprise Imaging solutions and DiA Imaging Analysis, a global leading provider of AI-based cardiac ultrasound […]

JanOne Inc. Announces the Issuance of U.S. Patent Covering a Method of Improving Nerve Function Using JAN101

Issuance of U.S. Patent 11,247,902 B2 Further Bolsters JanOne Inc.’s Intellectual Patent Portfolio LAS VEGAS, June 7, 2022 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced today that a patent was issued that covers a method of improving nerve function using […]